Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy

Am J Transplant. 2015 Dec;15(12):3081-94. doi: 10.1111/ajt.13399. Epub 2015 Jul 30.

Abstract

Recent studies have shown that the quantity of donor-reactive memory T cells is an important factor in determining the relative heterologous immunity barrier posed during transplantation. Here, we hypothesized that the quality of T cell memory also potently influences the response to costimulation blockade-based immunosuppression. Using a murine skin graft model of CD8(+) memory T cell-mediated costimulation blockade resistance, we elicited donor-reactive memory T cells using three distinct types of pathogen infections. Strikingly, we observed differential efficacy of a costimulation and integrin blockade regimen based on the type of pathogen used to elicit the donor-reactive memory T cell response. Intriguingly, the most immunosuppression-sensitive memory T cell populations were composed primarily of central memory cells that possessed greater recall potential, exhibited a less differentiated phenotype, and contained more multi-cytokine producers. These data, therefore, demonstrate that the memory T cell barrier is dependent on the specific type of pathogen infection via which the donor-reactive memory T cells are elicited, and suggest that the immune stimulation history of a given transplant patient may profoundly influence the relative barrier posed by heterologous immunity during transplantation.

Keywords: T cell biology; basic (laboratory) research/science; costimulation; fusion proteins and monoclonal antibodies: adhesion molecule specific; fusion proteins and monoclonal antibodies: costimulation molecule specific; immunobiology; immunosuppressant; immunosuppression/immune modulation; translational research/science.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteria / pathogenicity*
  • Bacterial Infections / etiology
  • Bacterial Infections / therapy*
  • CD8-Positive T-Lymphocytes / immunology*
  • Graft Rejection / etiology
  • Graft Rejection / therapy*
  • Graft Survival
  • Humans
  • Immunologic Memory / immunology*
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Integrins / antagonists & inhibitors*
  • Lymphocyte Activation / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Risk Factors
  • Skin Transplantation*
  • Tissue Donors*
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Integrins